CustoMED Secures $6 Million to Expand AI-Driven 3D Printing for Orthopedic Solutions

CustoMED Secures $6 Million for AI-Driven Surgery Solutions

CustoMED, an innovative company that specializes in developing AI-driven, patient-specific orthopedic surgery solutions, has announced the successful completion of its seed funding round, raising a total of $6 million. This funding is designed to accelerate the global deployment of its cutting-edge, 3D printed surgical solutions, which aim to enhance both the speed and precision of orthopedic surgeries.

Groundbreaking Technology

At the heart of CustoMED’s platform is its ability to utilize artificial intelligence and automation to create patient-specific surgical tools and implants. The technology dramatically shortens the production time for these crucial surgical aids, transforming a process that typically takes weeks into one that can be completed in just minutes. This is achieved through a cloud-based platform that generates custom solutions directly from the surgeon's pre-operative plans, allowing for seamless integration into existing surgical workflows.

CustoMED’s innovative approach not only reduces the chances of intraoperative errors but also leads to more predictable outcomes, giving surgeons the freedom to maintain complete creative and clinical control over their procedures. With hundreds of successful surgeries already completed around the world, including a growing number in the coming year, the company is rapidly demonstrating the effectiveness of its technology.

Visionary Leadership

CustoMED was co-founded by a trio of visionaries: Dr. Amit Zabatani, Or Benifla, and Alon Jacobi, who stemmed from the 3D Printing Innovation Lab at Sheba Medical Center. This lab, established in 2018 under the leadership of Dr. Dina Orkin, has been a critical player in integrating 3D printing into routine patient care, supporting hundreds of surgical operations across various medical departments.

Prof. Eyal Zimlichman, who is the founder and director of the ARC Innovation ecosystem at Sheba Medical Center, highlighted CustoMED's role in